Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,54 HKD | +4,53 % | -45,61 % | -61,75 % |
Resumen de negocios
Número de empleados: 435
Ventas por actividad
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biologics of Oncology
100,0
%
| 194 | 100,0 % | 242 | 100,0 % | +24,60 % |
Ventas por región
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 194 | 100,0 % | 242 | 100,0 % | +24,60 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ting Xu
CEO | Chief Executive Officer | 51 | 01/11/08 |
Jing Han
CMP | Compliance Officer | 51 | 02/11/21 |
Jinbo Wang
CTO | Chief Tech/Sci/R&D Officer | 50 | 19/03/18 |
Liang Kong
CTO | Chief Tech/Sci/R&D Officer | 44 | 01/06/18 |
Lu Amy Sun
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/19 |
Yang Liu
COO | Chief Operating Officer | 52 | 01/10/18 |
Jin Nan Wang
IRC | Investor Relations Contact | 42 | - |
Shaowei Yang
PRN | Corporate Officer/Principal | 48 | 13/06/17 |
Mike Liu
PRN | Corporate Officer/Principal | 58 | 01/05/18 |
Lok Yee Chan
SEC | Corporate Secretary | 35 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Cheng Wei
BRD | Director/Board Member | 56 | 24/11/19 |
Ting Xu
CEO | Chief Executive Officer | 51 | 01/11/08 |
Yang Liu
COO | Chief Operating Officer | 52 | 01/10/18 |
Dong Wu
BRD | Director/Board Member | 54 | 24/11/19 |
Zijian Guo
BRD | Director/Board Member | 63 | 27/08/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 964 923 807 | 474 870 857 ( 49,21 %) | 0 | 49,21 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-61,75 % | 313 M | |
+43,36 % | 54,64 mil M | |
-5,31 % | 39,92 mil M | |
+37,52 % | 38,82 mil M | |
+14,75 % | 26,86 mil M | |
-12,56 % | 26,22 mil M | |
-22,45 % | 18,78 mil M | |
+25,12 % | 12,21 mil M | |
+0,04 % | 12,16 mil M | |
+26,04 % | 11,94 mil M |
- Bolsa de valores
- Acciones
- Acción 9966
- Empresa Alphamab Oncology